Impact of Clomiphene Citrate on the Steroid Profile in Dysmetabolic Men with Low Testosterone Levels

Abstract

Clomiphene citrate (CC) in male hypogonadism increases testosterone (T) and estrogen levels by stimulating pituitary gonadotropin release. Our group confirmed these hormonal changes in a randomized, cross-over, double-blind trial of CC versus placebo in addition to metformin, conducted in 21 obese dysmetabolic men with low T levels. However, we hypothesize that based on its mechanism of action, CC may directly or indirectly affect adrenal steroidogenesis. The aim of this sub-study was to better understand the changes in steroid levels and metabolism induced by CC treatment. We assessed 17α-hydroxypregnelone (17αOH-P5), dehydroepiandrosterone (DHEA), progesterone (P4), 17α-hydroxyprogesterone (17αOH-P4), androstenedione (A), T, dihydrotestosterone (DHT), estrone (E1), 17β-estradiol (E2), 11-deoxycortisol (11 S), cortisol (F), and cortisone (E) by LC-MS/MS, and corticosteroid binding globulin (CBG) by ELISA, before and after each treatment. In addition, free-F and steroid product/precursor ratios were calculated. We observed a significant change in serum levels induced by CC compared with placebo for 17αOH-P4, DHT, T, E2, E1, F, E, and CBG, but not free-F. In addition, compared to placebo, CC induced higher 17αOH-P4/P4, E2/E1, 17αOH-P4/17αOH-P5, A/17αOH-P4, T/A, E1/A, F/11 S, and F/E ratios. Therefore, besides the CC stimulating effect on testis steroidogenesis, our study showed increased F, E, but not free-F, levels, indicating changes in steroid metabolism rather than adrenal secretion stimulation. The steroid profiling also revealed the CC stimulation of the Δ5 rather than the Δ4 pathway, thus indicating considerable testicular involvement in the increased androgen secretion.

Key words

functional hypogonadism - clomiphene citrate - testosterone - cortisol

Publication History

Received: 06 March 2021

Accepted after revision: 24 June 2021

Article published online:
12 August 2021

• References

• 1 Bhasin S, Brito JP, Cunningham GL. et al Testosterone therapy in men with hypogonadism: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2018; 103: 1-30
• 2 Grossmann M, Matsumoto AM. Perspective on middle-aged and older men with functional hypogonadism: focus on holistic management. J Clin Endocrinol Metab 2017; 102: 1067-1075
• 3 McCullough A. Alternatives to testosterone replacement: testosterone restoration. Asian J Androl 2015; 17: 201-205
• 4 Tajar A, Forti G, O'Neill TW. et al Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European male ageing study. J Clin Endocrinol Metab 2010; 95: 810-1818
• 5 Pelusi C, Giagulli VA, Baccini M. et al Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study. PLoSOne 2017; 12: 1-16
• 6 Soares AH, Horie NC, Chiang LAP. et al Effects of clomiphene citrate on male obesity-associated hypogonadism: a randomized, double-blind, placebo-controlled study. Int J Obesity (Lond) 2018; 42: 953-963
• 7 Harkness RA, Bell ET, Loraine JA. et al The effects of clomiphene on endocrine function in male patients with adrenocortical insufficiency and following castration. Acta Endocrinol (Copenh) 1968; 58: 38-48
• 8 Kampmann JP, Schonau Jorgensen F. et al Rise in dehydroepiandrosterone and oestrogens during clomiphene administration in normal men. Acta Endocrinol (Copenh) 1976; 83: 166-172
• 9 Kićović PM, Subotić Z. Effects of clomiphene on normal human adrenal cortex. Am J Obstet Gynecol 1970; 108: 1077-1079
• 10 Marshall JC, Anderson DC, Burke CW. et al Clomiphene citrate in men: increase of cortisol, luteinizing hormone, testosterone and steroid-binding globulins. J Endocrinol 1972; 53: 261-276
• 11 Feelders RA, Lamberts SW, Hofland LJ. et al Luteinizing hormone (LH)-responsive Cushing's syndrome: the demonstration of LH receptor messenger ribonucleic acid in hyperplastic adrenal cells, which respond to chorionic gonadotropin and serotonin agonists in vitro. J Clin Endocrinol Metab 2003; 88: 230-237
• 12 Lacroix A, Ndiaye N, Tremblay J. et al Ectopic and abnormal hormone receptors in adrenal Cushing's syndrome. End Rev 2001; 22: 75-110
• 13 Mircescu H, Jilwan J, N'Diaye N. et al Are ectopic or abnormal membrane hormone receptors frequently present in adrenal Cushing's syndrome?. J Clin Endocrinol Metab 2000; 85: 3531-3536
• 14 Pabon JE, Li X, Lei ZM. et al Novel presence of luteinizing hormone/chorionic gonadotropin receptors in human adrenal glands. J Clin Endocrinol Metab 1966; 81: 2397-2400
• 15 Bae YU, Kratzsch J. Cortisol-binding globulin: modulating mechanism of bioavailability of cortisol and its clinical implications. Best Pract Res Clin Endocrinol Metab 2015; 29: 761-772
• 16 Saxena AR, Seely EW. Luteinizing hormone correlates with adrenal function in postmenopausal women. Menopause 2012; 19: 1280-1283
• 17 Kero J, Poutanen M, Zhang FP. et al Elevated luteinizing hormone induces expression of its receptor and promotes steroidogenesis in the adrenal cortex. J Clin Invest 2000; 105: 633-641
• 18 Yin X, Liu J. Estrogen receptor α plays an important role in Cushing’s syndrome during pregnancy. Med Hypotheses 2020; 143: 109817
• 19 Marni AN, Zeng A, Meyer EJ. et al Differential Effects of Estrogen on Corticosteroid-Binding Globulin Forms Suggests Reduced Cleavage in Pregnancy. J Endocr Soc 2017; 13: 202-210
• 20 Miller WL, Auchus RJ. The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev 2011; 32: 81-151
• 21 Schiffer L, Arlt W, Storbeck KH. Intracrine androgen biosynthesis, metabolism and action revisited. Mol Cel Endocrinol 2018; 465: 4-26
• 22 American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010; 33: 11-61
• 23 Fanelli F, Belluomo I, Di Lallo VD. et al Serum steroid profiling by isotopic dilution-liquid chromatography-mass spectrometry: comparison with current immunoassays and reference intervals in healthy adults. Steroids 2011; 76: 244-253
• 24 Fanelli F, Fazzini A, Mezzullo M. et al Sex hormone and steroid precursor measurement by simple and rapid lc-ms/ms: comparison with current routine immunoassays. 18th European Congress of Endocrinology, Munich, Endocrine Abstract 2016; EP 658
• 25 Coolens JL, Van Baelen H, Heyns W. Clinical use of unbound plasma cortisol as calculated from total cortisol and corticosteroid binding globulin. J Steroid Biochem 1987; 26: 197-202
• 26 Pretorius CJ, Galligan JP, McWhinney BC. et al Free cortisol methods comparison: ultrafiltration, equilibrium dialysis, tracer dilution, tandem mass spectrometry, and calculated free cortisol. Clin Chim Acta 2011; 412: 1043-1047
• 27 Goldstein SR, Siddhanti S, Ciaccia AV. et al A pharmacological review of selective oestrogen receptor modulators. Hum Reprod Update 2000; 3: 212-224
• 28 Liel Y. Clomiphene citrate in the treatment of idiopathic of functional hypogonadotropic hypogonadism in men. A case series and review of the literature. Endocr Pract 2017; 23: 279-287
• 29 Chua ME, Escusa KG, Luna S. et al Revisiting oestrogen antagonists (clomiphene or tamoxifen) as medical empiric therapy for idiopathic male infertility: a meta-analysis. Andrology 2013; 1: 749-757
• 30 Tenover JS, Bremner WJ. The effects of normal aging on the response of the pituitary-gonadal axis to chronic clomiphene administration in men. J Androl 1991; 12: 258-263
• 31 Guay AT, Bansal S, Heatley GJ. Effect of raising endogenous testosterone levels in impotent men with secondary hypogonadism: Double blind placebo controlled trial with clomiphene citrate. J Clin Endocrinol Metab 1995; 80: 3546-3552
• 32 Kaufman JM, Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocr Rev 2005; 26: 833-876
• 33 Kaufman JM. Mortality associated to late-onset hypogonadism: reasons not to treat with testosterone?. J Clin Endocrinol Metab 2014; 99: 1161-1163
• 34 ChV Rao, Zhou XL, Lei ZM. Functional luteinizing hormone/ chorionic gonadotropin receptors in human adrenal cortical H295R cells. Biol Reprod 2004; 71: 579-587
• 35 Alevizaki M, Saltiki K, Mantzou E. et al The adrenal gland may be a target of LH action in postmenopausal women. Eur J Endocrinol 2006; 154: 875-881
• 36 de Cremoux P, Rosenberg D, Goussard J. et al Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease. Endocr Relat Cancer 2008; 15: 465-474
• 37 Rosner W. The functions of corticosteroid-binding globulin and sex hormone-binding globulin: recent advances. Endocr Rev 1990; 11: 80-91
• 38 Pelusi C, Fanelli F, Baccini M. et al Effect of clomiphene citrate treatment on the Sertoli cells of dysmetabolic obese men with low testosterone levels. Clin Endocrinol (Oxf) 2020; 92: 38-45
• 39 Barbosa J, Seal US, Doe RP. Anti-estrogens and plasma proteins. I Clomiphene and isomers, ethamoxytriphetol, U-11,100A and U11,555A. J Clin Endocrinol Metab 1972; 36: 666-678
• 40 Dunn JF, Nisula BC, Rodbard D. Transport of steroid hormones: binding of 21 endogenous steroids to both testosterone-binding globulin and corticosteroid-binding globulin in human plasma. J Clin Endocrinol Metab 1981; 53: 58-68
• 41 Auchus RJ, Lee TC, Miller WL. Cytochrome b5 augments the 17,20-lyase activity of human P450c17 without direct electron. J Biol Chem 1998; 273: 3158-3165
• 42 Flück CE, Miller WL, Auchus RJ. The 17,20-lyase activity of cytochrome p450c17 from human fetal testis favors the delta5 steroidogenic pathway. J Clin Endocrinol Metab 2003; 88: 3762-3766
• 43 Giagulli VA, Vermeulen A. Leydig cell function in infertile men with idiopathic oligospermic infertility. J Clin Endocrinol Metab 1988; 66: 62-67
• 44 Glass AR, Vigersky RA. Resensitization of testosterone production in men after human chorionic gonadotropin-induced desensitization. J Clin Endocrinol Metab 1980; 51: 1395-1400
• 45 Pardridge WM. Transport of protein-bound hormones into tissues in vivo. Endocr Rev 1981; 2: 103-123
• 46 MacDonald PC, Madden JD, Brenner PF. et al Origin of estrogen in normal men and in women with testicular feminization. J Clin Endocrinol Metab 1979; 49: 905-916
• 47 de Ronde W, de Jong FH. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol 2011; 9: 93
• 48 Jarow JP, Chen H, Rosner TW. et al Assessment of the androgen environment within the human testis: minimally invasive method to obtain intratesticular fluid. J Androl 2001; 22: 640-645
• 49 Helo S, Ellen J, Mechlin C. et al A randomized prospective double-blind comparison trial of clomiphene citrate and anastrozole in raising testosterone in hypogonadal infertile men. J Sex Med 2015; 12: 1761-1769
• 50 Schulster M, Bernie AM, Ramasamy R. The role of estradiol in male reproductive function. Asian J Androl 2016; 18: 435-440
• 51 Ito T, Horton R. The source of plasma dihydrotestosterone in man. J Clin Invest 1971; 50: 1621-1627